IL6:

Chong Fu1, Longquan Wang2, Wenjiao Cai3

  • 1Department of Gastroenterology, Anqing Municipal Hospital, Anqing, Anhui, China.

Frontiers in immunology
|September 4, 2024
PubMed
概括

介素-6受体抑制剂在治疗异常性肺纤维化,帕金森病和2型糖尿病方面表现有前途. 然而,它们可能会增加喘和喘性肺炎的风险.